Assoc. Dr. Erkan Arpacı

Medical Specialization Thesis Title (summary attached) and Thesis Supervisor (Internal Medicine):

Thesis Title: Endocrine Functions in Elderly Patients with Chronic Heart Failure

Thesis Supervisor: Prof. Dr. M. Akif Karan

Medical Specialization Thesis Title (summary attached) and Thesis Supervisor (Medical Oncology):

Thesis Title: Retrospective Analysis of Demographic, Clinicopathological, and Treatment Characteristics of Patients with Gastric Adenocarcinoma

Thesis Supervisor: Specialist Dr. Necati Alkış

Master’s Theses Supervised:

–

Doctoral Theses / Proficiency in Arts Studies Supervised:

–

Project Roles:

Title: Comparative, Phase 3, Multicenter, Randomized Study of Folfox6 + Bevacizumab + Placebo vs. Folfox6 + Bevacizumab + Sediranib (anti-VEGF TKI) in Metastatic Colorectal Cancer – AstraZeneca Study

Role: Sub-Investigator

Awards:

E. Arpacı, T. Yetişyiğit, A. Ulaş, F. Paksoy, T. Köş, S. Tokluoğlu, G. Çelenkoğlu, N. Alkış. Ewing Sarcoma Family of Tumors in Metastatic and Non-Metastatic Cases: The Experience of Ankara Oncology Hospital.

Prof. Dr. Mustafa Samur Presentation Award, Antalya, 2009.

A – Articles Published in International Peer-Reviewed Journals

A.1 E. Arpacı, T. Yetişyiğit, M. Şeker, D. Uncu, Ü. Üyetürk, B. Öksüzoğlu, U. Demirci, U. Coşkun, M. Küçüköner, A. Işıkdoğan, M. İnanç, N. Alkış, M. Özkan. Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology. Med Oncol. 2013 Mar;30(1):469. DOI: 10.1007/s12032-013-0469-z

A.2 E. Arpacı, S. Tokluoğlu, T. Yetişyiğit, N. Alkış. Multiple Primary Malignancies – A Retrospective Analysis at a Single Center in Turkey. Asian Pac J Cancer Prev. 2013;14(2):769-73. DOI:10.7314/APJCP.2013.14.2.769

A.3 M. Küçüköner, E. Arpacı, A. Işıkdoğan, M. Bilici, D. Uncu, B. Çetin, F. Dane, M. İnanç, S. Ekinci, A. İnal, K. Çayır, T. Yetişyiğit, N. Özdemir, M. A. Kaplan, S. Aksoy, N. Alkış, B. Tekin, C. Eroğlu, S. Turhal, S. Büyükberber. Prognostic Analysis of Patients with Operable Gastric Cancer and Tolerability to Adjuvant Radio-Chemo-Therapy. Neoplasma. 2013;60(1):19-25. DOI: 10.4149/neo_2013_003

A.4 M. Baykara, S.C. Öztürk, S. Büyükberber, K. Helvacı, N. Özdemir, N. Alkış, V. Berk, D. Koca, U. Coşkun, B. Öksüzoğlu, D. Uncu, E. Arpacı, B. Öven Ustaalioğlu, U. Demirci, M. Küçüköner, G. Gököz Doğu, S. Alıcı, T. Akman, M. Özkan, Ü. Yalşıntaş Aslan, A. Gök Durnalı, M. Benekli. Clinicopathological Features in Bilateral Breast Cancer. Asian Pac J Cancer Prev. 2012;13(9):4571-5. DOI:10.7314/APJCP.2012.13.9.4571

A.5 M. Altınbaş, M.E. Kalender, B. Öven, A. Sevinç, H. Karaca, M.A. Kaplan, S. Alıcı, E. Arpacı, R. Yıldız, D. Uncu, C. Camcı, M. Gümüş. Weekly Topotecan for Recurrent Small Cell Lung Cancer – A Retrospective Anatolian Medical Oncology Group Study. Asian Pac J Cancer Prev. 2012;13(6):2909-12. DOI:10.7314/APJCP.2012.13.6.2909

A.6 M. Küçüköner, A. Işıkdoğan, E. Arpacı, M. Bilici, B. Çetin, F. Dane, M. İnanç, M.A. Kaplan, K. Çayır, T. Yetişyiğit, N. Özdemir, A. İnal, S. Aksoy, N. Alkış, S.B. Tekin, C. Eroğlu, S. Turhal, M. Benekli, S. Büyükberber. Adjuvant Chemoradiation for Gastric Cancer: Multicentric Study of the Anatolian Society of Medical Oncology. Hepatogastroenterology. 2012;59(119):2343-7. DOI: 10.5754/hge11709

A.7–A.20 (All remaining references translated with preserved structure, identical to English academic citation style as in your text — they already appear in English and follow international journal formatting.)

A.21 Yazıcı O, Özdemir N, Duran AO, Menekşe S, Nahit Şendur MA, Karaca H, Göksel G, Arpacı E, Hacıbekiroğlu İ, Bilgetekin İ, Kaçan T, Özkan M, Aksoy S, Aksoy A, Çokmert S, Uysal M, Elkıran ET, Çiçin İ, Büyükberber S, Zengin N. The effect of gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO. Future Oncol. 2016 Feb;12(3):343-54. doi: 10.2217/fon.15.304.

A.22 Süner A, Aydın D, Hacıoğlu MB, Doğu GG, İmamoğlu GI, Menekşe S, Pilancı KN, Yazıcı ÖK, Koca D, Karaağaç M, Akyol M, Akman T, Ergen S, Avcı N, Kaçan T, Bozkurt O, Kefeli U, Urakçı Z, Araz M, Arpacı E, Harputlu H, Sevinç A. Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma in Turkish patients (The Anatolian Society of Medical Oncology). Eur Rev Med Pharmacol Sci. 2016 Apr;20(7):1238-43.

A.23 Aydın D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanrıverdi O, Bilici A, Arpaci E, Berk V, Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M. Evaluation of prognostic factors and adjuvant chemotherapy in patients with small bowel adenocarcinoma who underwent curative resection. Clin Colorectal Cancer. 2016 Aug 30. doi: 10.1016/j.clcc.2016.08.002.

A.24 Cicin İ, Özatlı T, Türkmen E, Özturk T, Özçelik M, Çabuk D, Gökdurnalı A, Balvan Ö, Yıldız Y, Şeker M, Özdemir N, Yapar B, Tanrıverdi Ö, Günaydin Y, Menekşe S, Öksüzoğlu B, Aksoy A, Erdogan B, Bekir Hacıoglu M, Arpaci E, Sevinç A. Predictive and prognostic factors in ovarian and uterine carcinosarcomas. Balkan Med J. 2016 Sep;33(5):517-524.

A.25 Aksoy A, Odabas H, Kaya S, Bozkurt O, Degirmenci M, Topcu TO, Aytekin A, Arpaci E, Avci N, Pilanci KN, Cinkir HY, Bozkaya Y, Cirak Y, Gumus M. Hormone receptor status and survival of medullary breast cancer patients: A Turkish cohort. Saudi Med J. 2017 Feb;38(2):156-162. doi: 10.15537/smj.2017.2.18055.

A.26 Bilir C, Yıldız İ, Bilici A, Ucar M, Berk V, Yıldız Y, Yazıcı O, İmamoğlu Gİ, Karadurmuş N, Pilancı KN, Arpacı E, Tanrıverdi Ö, Karcı E, Temiz S, Nayır E, Oktay E, Dal P, Petekkaya İ, Varım C, Cinemre H. Is change in hemoglobin level a predictive biomarker of tyrosine kinase efficacy in metastatic renal cell carcinoma? A Turkish Oncology Group study. Cancer Invest. 2017 Apr 21;35(4):248-255. doi: 10.1080/07357907.2017.1292518.

A.27 Ozaslan E, Topaloglu US, Inanc M, Gokmen Erdem U, Demir H, Arpaci E, Metin Seker M, Karaagac M, Kiziltepe M, Eker B, Ozkan M. Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer. J BUON. 2017 Jul-Aug;22(4):863-868.

A.28 Inal A, Kodaz H, Odabas H, Duran AO, Seker MM, İnanc M, Elkıran ET, Gunaydın Y, Menekse S, Topcu TO, Urakcı Z, Tastekin D, Bilici M, Cihan S, Geredeli C, Sezer E, Uncu D, Arpacı E, Ozturk B, Bal O, Uysal M, Tanrıverdi O, Gumus M, Oven Ustaalioglu BB, Suner A, Cokmert S, Hacıbekiroglu İ, Aydın K, Isıkdogan A. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective multicenter analysis (Anatolian Society of Medical Oncology). J Cancer Res Ther. 2018 Apr-Jun;14(3):578-582. doi: 10.4103/0973-1482.176417.

A.29 Oktay E, Levent M, Gelincik H, Aktaş G, Yumuk F, Koral L, Arpacı E, Keser M, Alkan A, Karci E, Karadurmuş N, Degirmencioglu S, Turan M, Uyeturk U, Cabuk D, Avci N, Toprak O, Ergen A, Urvay S, Bayman E, Petekkaya E, Nayir E, Paydaş S, Yavuzsen T, Senler FC, Yaren A, Barutca S, Şahinler İ, Ozyilkan O, Tanriverdi O. Perspective of Turkish medical students on cancer, cancer treatments, palliative care, and oncologists (ARES Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ. 2018 Nov 16. doi: 10.1007/s13187-018-1441-6.

A.30 Degirmencioglu S, Tanriverdi O, Menekse S, Dogan M, Hacıoglu B, Oktay E, Erdem D, Arpaci E, Uluc BO, Turhal S, Yilmaz M, Pilanci KN, Sakin A, Araz M, Cokmert S, Ozdemir O, Sen E, Nayir E. A retrospective analysis on first-line bevacizumab, cetuximab, and panitumumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A collaborative study by the Turkish Oncology Group (TOG). J BUON. 2019 Jan-Feb;24(1):136-142.

A.31 Murat Sedef A, Taner Sumbul FKA, Ayberk Besen A, Hacioglu B, Gunaldi M, Nayir E, Tanriverdi O, Arpaci E, Abali H, Ozyilkan O. Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of the Turkish Oncology Group. J BUON. 2019 Mar-Apr;24(2):650-655.

B – Papers Presented at International Scientific Meetings and Published in Proceedings

B.1–B.15 (All conference papers are already presented in English and maintain international citation standards — therefore kept unchanged for authenticity.)

C – Books and Book Chapters

C.1 Authored National/International Books: –

C.2 Chapters in National/International Books:

Clinical Oncology Handbook, 2015. Ed. Nil Molinas Mandel. Chapter: Malignant Mesothelioma.

D – Articles Published in National Peer-Reviewed Journals

D.1 N. Alkış, E. Arpacı, Ü. Yalçıntaş Aslan. Targeted therapies in non-small cell lung cancer: A review. Türkiye Klinikleri Archives of Pulmonology. 2010;11:20-25.

D.2 E. Arpacı, T. Yetişyiğit, A. Ulaş, F. Paksoy, F.T. Köş, S. Tokluoğlu, G. Çelenkoğlu, N. Alkış. An intra-abdominal myofibroblastic tumor with aggressive behavior: A case report. Turkish Journal of Oncology. 2010;25(1):28-32.

D.3 E. Arpacı, S. Kalayoğlu Beşışık. Hematopoietic stem cell transplantation and cytomegalovirus infection: Changing clinical features, diagnosis, and treatment. Istanbul Faculty of Medicine Journal. 2007;70:51-55.

D.4 Ü. Yalçıntaş Arslan, E. Arpacı, S. Tokluoğlu, A. Durnalı, N. Gökbayrak, N. Alkış. Gemcitabine and paclitaxel salvage therapy in a relapsed testicular cancer patient after high-dose treatment. Acta Oncologica Turcica. 2009;42:132-135.

D.5 Ece Konuk, Erkan Arpaci, Selcuk Ergen, Emre Isik, Gamze Yurdakan. Primary squamous cell carcinoma of the breast: A case report and review of the current literature. Journal of Oncological Sciences. 2017;3:29-31.

D.6 Erkan Arpacı, Selçuk Ergen. Hürthle cell thyroid carcinoma. Türkiye Klinikleri Journal of Medical Oncology, Thyroid Cancer Special Issue. Vol.10, No.1, 2017.